Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration

Effect of Repeated Intravitreal Ranibizumab and Aflibercept Injections on the Cornea in Patients with Age-Related Macular Degeneration

Purpose. To assess the effect of repeated intravitreal ranibizumab injections (RI) and aflibercept injections (AI) on the corneal endothelium and central corneal thickness (CCT) in patients with age-related macular degeneration (AMD). Materials and Methods. In the retrospective study, 110 eyes of 10...

Full description

Saved in:

Bibliographic Details
Main Authors:	Beata Urban, Magdalena Szwabowicz, Alina Bakunowicz-Łazarczyk
Format:	Article
Language:	English
Published:	Wiley 2020-01-01
Series:	Journal of Ophthalmology
Online Access:	http://dx.doi.org/10.1155/2020/4928905
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Clinical Response To Switch From Ranibizumab To Aflibercept In Wet Age-Related Macular Degeneration
by: Bhagya Weerasinghe, et al.
Published: (2021-01-01)

Assessment of effect of intravitreal ranibizumab injection on the ocular blood flow in patients with neovascular age-related macular degeneration
by: V. V. Neroev, et al.
Published: (2014-07-01)

Effects of Intravitreal Ranibizumab Injection on Chinese Patients with Wet Age-Related Macular Degeneration: 5-Year Follow-Up Results
by: Yingyi Lu, et al.
Published: (2016-01-01)

One-Year Results of Photodynamic Therapy Combined with Intravitreal Ranibizumab for Exudative Age-Related Macular Degeneration
by: Tomoko Nakamura, et al.
Published: (2012-01-01)

Short-Term Outcomes following “Switching” to Monthly Ranibizumab in Neovascular Age-Related Macular Degeneration Showing Insufficient Response to Bimonthly Aflibercept
by: Jong Suk Lee, et al.
Published: (2021-01-01)

Corrigendum: Efficacy and safety of intravitreal injection of aflibercept biosimilar for treating diabetic macular edema
by: Gaixia Zhai, et al.
Published: (2025-05-01)

Two-year results of switching to intravitreal administration of faricimab in patients with aflibercept-refractory neovascular age-related macular degeneration
by: Masaaki Saito, et al.
Published: (2025-08-01)

Individualized Therapy with Ranibizumab in Wet Age-Related Macular Degeneration
by: Alfredo García-Layana, et al.
Published: (2015-01-01)

Endophthalmitis in Retinopathy of Prematurity after Intravitreal Aflibercept Injection
by: Elcin Suren, et al.
Published: (2020-01-01)

Safety of Intravitreal Injection of Biosimilar of Aflibercept in Rabbit Eyes
by: Alireza Lashay, et al.
Published: (2020-01-01)

Intravitreal Ranibizumab versus Razumab in treatment naïve diabetic macular edema
by: Dhandapani A, et al.
Published: (2025-06-01)

Managing Choroidal Neovascularization in Pseudoxanthoma Elasticum: Outcomes of Vitrectomy and Intravitreal Ranibizumab/Aflibercept Therapy—A Case Report
by: Kazuya Yamashita, et al.
Published: (2025-01-01)

Effect of combined mature cataract surgery and intravitreal ranibizumab injection in eyes with pre-existing diabetic macular edema
by: Yao Shen, et al.
Published: (2025-08-01)

Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema
by: Yoshinari Saima, et al.
Published: (2024-06-01)

Pharmacoeconomic research of using aflibercept in patients with the wet age-related macular degeneration
by: S. V. Nedogoda, et al.
Published: (2020-03-01)

Pars Plana Vitrectomy versus Intravitreal Injection of Ranibizumab in the Treatment of Diabetic Macular Edema Associated with Vitreomacular Interface Abnormalities
by: Hassan Elkayal, et al.
Published: (2021-01-01)

Effect of multiple intravitreal injections of conbercept on the cornea in patients with branch retinal vein occlusion-induced macular edema
by: Gaixia Zhai, et al.
Published: (2025-06-01)

Author Correction: Effects of switching from intravitreal injection of aflibercept to faricimab on ocular blood flow in patients with diabetic macular edema
by: Yoshinari Saima, et al.
Published: (2025-06-01)

Effects of Intravitreal Aflibercept on the Systemic Insulin-like Growth Factor-I and Vascular Endothelial Growth Factor-A in Patients with Diabetic Retinopathy and Age-Related Macular Degeneration
by: Anna Lena Huber, et al.
Published: (2021-01-01)

Efficacy of aflibercept in patients with neovascular age-related macular degeneration when combined with cataract surgery
by: A. A. Kuznetsov, et al.
Published: (2018-10-01)

Clinical Phenotypes of Patients with Neovascular Age-Related Macular Degeneration and Poor Response to Aflibercept Treatment
by: V. G. Likhvantseva, et al.
Published: (2022-10-01)

Comparison of the Efficacy of Intravitreal Aflibercept and Bevacizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion
by: Jia-Kang Wang, et al.
Published: (2016-01-01)

Efficacy and Safety of Aflibercept Biosimilars Relative to Reference Aflibercept Therapy for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
by: Aljuhani HS, et al.
Published: (2025-06-01)

Successful Resolution of Preretinal Haemorrhage with Intravitreal Ranibizumab
by: Baharuddin Noorlaila, et al.
Published: (2016-01-01)

Transitioning from Aflibercept to Biosimilar Ranibizumab in Diabetic Macular Edema (DME): (The TRANSFORM-DME Trial) a Multicenter Observational Study
by: Chakraborty D, et al.
Published: (2024-11-01)

An Influence of Birth Weight, Gestational Age, and Apgar Score on Pattern Visual Evoked Potentials in Children with History of Prematurity
by: Marta Michalczuk, et al.
Published: (2015-01-01)

Unraveling the effects of serial intravitreal Aflibercept injections on the ocular surface of patients with glaucoma and retinal comorbidity
by: Luca Agnifili, et al.
Published: (2025-04-01)

Prophylaxis of Macular Edema with Intravitreal Ranibizumab in Patients with Diabetic Retinopathy after Cataract Surgery: A Pilot Study
by: Patricia Udaondo, et al.
Published: (2011-01-01)

Evaluation of Corneal Endothelium in Adolescents with Juvenile Glaucoma
by: Beata Urban, et al.
Published: (2015-01-01)

Is Spectral-Domain Optical Coherence Tomography Essential for Flexible Treatment Regimens with Ranibizumab for Neovascular Age-Related Macular Degeneration?
by: Abdullah Ozkaya, et al.
Published: (2013-01-01)

The effect of intravitreal administration of bevacizumab on macular edema and visual acuity in age-related macular degeneration with subfoveolar choroidal neovascularisation
by: Ristić Dragana, et al.
Published: (2013-01-01)

Macular Hole Progression following Ocriplasmin Intravitreal Injection
by: Edward Casswell, et al.
Published: (2014-01-01)

Early Real-World Outcomes of Switching to 8 mg Aflibercept for Neovascular Age-Related Macular Degeneration in the United Kingdom
by: Muiz Musadiq, et al.
Published: (2025-06-01)

Treatment Regimens with Ranibizumab in Neovascular Age-Related Macular Degeneration: Real-World Results from the PACIFIC Study Author List
by: Lorenz K, et al.
Published: (2025-08-01)

Comparisons of One to Three Monthly Injections of Aflibercept for Diabetic Macular Edema by Practical Protocol
by: Yuko Hayashi, et al.
Published: (2021-01-01)

Evaluation of the Effect of Repeated Intravitreal Bevacizumab Injections on the Macular Microvasculature of a Diabetic Patient Using Optical Coherence Tomography Angiography
by: Ayman G. Elnahry, et al.
Published: (2019-01-01)

Repeat Intravitreal Dexamethasone Implant for Refractory Cystoid Macular Edema in Syphilitic Uveitis
by: Cassandra C. Lautredou, et al.
Published: (2018-01-01)

Clinical Efficacy of Intravitreal Ranibizumab in Early and Mid-Idiopathic Choroidal Neovascularization
by: Chuanfeng Fan, et al.
Published: (2014-01-01)

Intravitreal Ranibizumab for Treatment of Posttraumatic Choroidal Neovascularization: a Case Report
by: A. N. Kulikov, et al.
Published: (2021-10-01)

Four-Year Outcome of Aflibercept Treatment-Naïve Patients for Neovascular Age-Related Macular Degeneration: Evidence from a Clinical Setting
by: Yanel Gayadine-Harricham, et al.
Published: (2020-01-01)